 |
인쇄하기
취소
|
SK Chemicals to introduce Toray's TRK-820
SK Chemicals announced on June 27 that it has concluded a licensing agreement with Toray Inc. of Tokyo, Japan, for the introduction of TRK-820 (nalfurafine HCl).
TRK-820 is a highly selective kappa opioid receptor agonist that has completed multiple Phase II studies for the treatment of uremic pruritus, a severe itching condition in dialysis patients.
Uremic pruritus is a systemic itching...
TRK-820 is a highly selective kappa opioid receptor agonist that has completed multiple Phase II studies for the treatment of uremic pruritus, a severe itching condition in dialysis patients.
Uremic pruritus is a systemic itching...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.